Get started
Author

Yutaka Enomoto

Observed names: Enomoto Yutaka, Enomoto, Yutaka, Y Enomoto, Y. Enomoto, YUTAKA ENOMOTO
ORCID: 0000-0002-6831-4896
Observed ORCID: 0000-0002-6831-4896
OpenAlex ID: A5039958599
Idiopathic retroperitoneal fibrosis, inflammatory aortic aneurysm, and inflammatory pericarditis—Retrospective analysis of 11 case histories
2011 · Aiko Sakamoto, Ryozo Nagai, et al. · Journal of Cardiology · 78
PDF
Assessment of lower urinary tract symptoms in men by international prostate symptom score and core lower urinary tract symptom score
2011 · Tetsuya Fujimura, Haruki Kume, et al. · British Journal of Urology · 55
Pretreatment neutrophil‐to‐lymphocyte ratio as an independent predictor of survival in patients with metastatic urothelial carcinoma: A multi‐institutional study
2015 · Satoru Taguchi, Tohru Nakagawa, et al. · International Journal of Urology · 53
Prognostic Factors for Renal Cell Carcinoma With Bone Metastasis: Who Are the Long-Term Survivors?
2011 · Haruki Kume, Shigenori Kakutani, et al. · The Journal of Urology · 52
Association between lower urinary tract symptoms and sexual dysfunction assessed using the core lower urinary tract symptom score and International index of erectile function-5 questionnaires
2012 · Masaki Nakamura, Tetsuya Fujimura, et al. · The Aging Male · 42
PDF
A pilot study of autologous tumor lysate-loaded dendritic cell vaccination combined with sunitinib for metastatic renal cell carcinoma
2014 · Hirokazu Matsushita, Yutaka Enomoto, et al. · Journal for ImmunoTherapy of Cancer · 37
PDF
Phase I trial of TAK‐385 in hormone treatment‐naïve Japanese patients with nonmetastatic prostate cancer
2019 · Hiroyoshi Suzuki, Hiroji Uemura, et al. · Cancer Medicine · 31
PDF
Management trends, angioembolization performance and multiorgan injury indicators of renal trauma from Japanese administrative claims database
2012 · Toru Sugihara, Hideo Yasunaga, et al. · International Journal of Urology · 31
Enfortumab vedotin versus platinum rechallenge in post‐platinum, post‐pembrolizumab advanced urothelial carcinoma: A multicenter propensity score‐matched study
2023 · Satoru Taguchi, Taketo Kawai, et al. · International Journal of Urology · 30
Impact of immune-related adverse events on the therapeutic efficacy of pembrolizumab in urothelial carcinoma: a multicenter retrospective study using time-dependent analysis
2022 · Taketo Kawai, Satoru Taguchi, et al. · Journal for ImmunoTherapy of Cancer · 30
PDF
Reduction of prostate cancer incidence by naftopidil, an α1‐adrenoceptor antagonist and transforming growth factor‐β signaling inhibitor
2013 · Daisuke Yamada, Hiroaki Nishimatsu, et al. · International Journal of Urology · 30
PDF
Distant Metastasis of Renal Cell Carcinoma With a Diameter of 3 cm or Less—Which is Aggressive Cancer?
2010 · Haruki Kume, Motofumi Suzuki, et al. · The Journal of Urology · 30
Nomogram for predicting survival of postcystectomy recurrent urothelial carcinoma of the bladder
2017 · Tohru Nakagawa, Satoru Taguchi, et al. · Urologic Oncology Seminars and Original Investigations · 29
Core lower urinary tract symptom score (CLSS) for the assessment of female lower urinary tract symptoms: A comparative study
2011 · Tetsuya Fujimura, Haruki Kume, et al. · International Journal of Urology · 28
Prognostic significance of the albumin-to-globulin ratio for advanced urothelial carcinoma treated with pembrolizumab: a multicenter retrospective study
2021 · Satoru Taguchi, Taketo Kawai, et al. · Scientific Reports · 24
PDF
Validation of major prognostic models for metastatic urothelial carcinoma using a multi-institutional cohort of the real world
2015 · Satoru Taguchi, Tohru Nakagawa, et al. · World Journal of Urology · 24
A replication study examining three common single‐nucleotide polymorphisms and the risk of prostate cancer in a Japanese population
2010 · Miao Liu, Motofumi Suzuki, et al. · The Prostate · 24
Maximum tumor diameter: a simple independent predictor for biochemical recurrence after radical prostatectomy
2010 · H Fukuhara, H Kume, et al. · Prostate Cancer and Prostatic Diseases · 23
Oncologic Outcome of Metastasectomy for Urothelial Carcinoma: Who Is the Best Candidate?
2017 · Tohru Nakagawa, Satoru Taguchi, et al. · Annals of Surgical Oncology · 20
Bladder endometriosis developed after long‐term estrogen therapy for prostate cancer
2012 · Satoru Taguchi, Yutaka Enomoto, et al. · International Journal of Urology · 20
PDF
Clinical evaluation of two consecutive UroVysion fluorescence in situ hybridization tests to detect intravesical recurrence of bladder cancer: a prospective blinded comparative study in Japan
2018 · Takahiro Kojima, Hiroyuki Nishiyama, et al. · International Journal of Clinical Oncology · 19
Improved survival in real‐world patients with advanced urothelial carcinoma: A multicenter propensity score‐matched cohort study comparing a period before the introduction of pembrolizumab (2003–2011) and a more recent period (2016–2020)
2022 · Satoru Taguchi, Taketo Kawai, et al. · International Journal of Urology · 18
PDF
Tumor regression by CD4 T-cells primed with dendritic/tumor fusion cell vaccines.
2014 · Shigeo Koido, Yutaka Enomoto, et al. · PubMed · 16
Improvement of symptoms of aging in males by a preparation LEOPIN ROYAL containing aged garlic extract and other five of natural medicines – comparison with traditional herbal medicines (Kampo)
2014 · Hiroaki Nishimatsu, Tadaichi Kitamura, et al. · The Aging Male · 16
PDF
Clinical significance and risk factors of urethrovesical anastomotic urinary leakage following robot-assisted radical prostatectomy: a multi-institutional study
2021 · Shigenori Kakutani, Yuta Takeshima, et al. · BMC Urology · 15
PDF
Works count: 80
Citation count: 957
H-index: 20
I10-index: 32
Year
Topic
Type